78502794

Information

• Trademark
• 78502794

• Source

• Serial Number

  78502794

• Registration Number

  3152858

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 35 - Advertising
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  October 20, 2004
  20 years ago

• Registration Date

  October 10, 2006
  18 years ago

• Transaction Date

  June 20, 2017
  7 years ago

• Status Date

  May 12, 2017
  7 years ago

• Published for Opposition Date

  July 18, 2006
  18 years ago

• Location Date

  May 20, 2013
  11 years ago

• Status Code

  710

• Employee Name

  TIERNEY, MARGERY ANN

• Attorney Docket Number

  S9133

  Attorney Name

  Gary D. Krugman

  Law Office Assigned Location Code

  M20

• Owners

  • PAION DEUTSHLAND GMBH
  • Paion Company, Limited

Case File Statements

• CC0000: Color is not claimed as a feature of the mark.
• GS0011: Reagents for scientific or medical research use; diagnostic preparations or reagents for scientific or research use, biochemical reagents for scientific or medical research use; biochemical diagnostic preparations or reagents for scientific or research use
• GS0051: Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment[ and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances,] nervous diseases, [diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood clotting test kits comprised of medical diagnostic reagents;] medical and clinical diagnostic reagents for clinical or medical laboratory use
• GS0101: [Laboratory devices for medical and pharmaceutical investigations, namely, portable medical devices for conducting medical diagnostic tests and blood specimen analysis of the human blood clotting system; medical devices, namely, coated catheters, medical stents, surgical implants comprising artificial materials; membranes intended for medical use, namely, filters for dialysis, hemofiltration]
• GS0351: [Computerized database management, namely, processing data for third parties]
• GS0411: [Educational services, namely, providing seminars, informational events and/or workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, gendiagnostics]
• GS0421: [Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; licensing of intellectual property; services of a biotechnological laboratory, namely, conducting lab research for others in the field of drug research and development; pharmaceutical consulting, namely, providing pharmaceutical advice to others regarding governmental regulatory laws and practices, performing pre-clinical studies, quality control; ]preparation of expert opinions in the field of[ chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry], product research and development of medical devices and pharmaceutical preparations, [and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries;] performance of pre-clinical studies, namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products[; bio-chemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment;] scientific research on and development of[ medical diagnostic equipment and] pharmaceutical preparations and products for the treatment of[ tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances,] nervous diseases, [diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases,] pain [and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment]

Case File Event Statements

• 5/12/2017 - 7 years ago

  29 - CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 Type: CAEX

• 10/10/2015 - 9 years ago

  28 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2

• 5/20/2013 - 11 years ago

  27 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85

• 5/20/2013 - 11 years ago

  26 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P

• 4/4/2013 - 11 years ago

  25 - REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Type: 815F

• 4/18/2013 - 11 years ago

  24 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 4/4/2013 - 11 years ago

  23 - TEAS SECTION 8 & 15 RECEIVED Type: E815

• 10/10/2006 - 18 years ago

  22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 7/18/2006 - 18 years ago

  21 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/28/2006 - 18 years ago

  20 - NOTICE OF PUBLICATION Type: NPUB

• 5/25/2006 - 18 years ago

  19 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 5/19/2006 - 18 years ago

  18 - ASSIGNED TO LIE Type: ALIE

• 5/4/2006 - 18 years ago

  17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/4/2006 - 18 years ago

  16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 5/4/2006 - 18 years ago

  15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 5/4/2006 - 18 years ago

  14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 4/20/2006 - 18 years ago

  13 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 3/23/2006 - 18 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/23/2006 - 18 years ago

  11 - PAPER RECEIVED Type: MAIL

• 2/14/2006 - 18 years ago

  10 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 8/10/2005 - 19 years ago

  9 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 8/10/2005 - 19 years ago

  8 - SUSPENSION LETTER WRITTEN Type: CNSL

• 8/4/2005 - 19 years ago

  7 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 7/27/2005 - 19 years ago

  6 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/27/2005 - 19 years ago

  5 - PAPER RECEIVED Type: MAIL

• 5/24/2005 - 19 years ago

  4 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/24/2005 - 19 years ago

  3 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/24/2005 - 19 years ago

  2 - ASSIGNED TO EXAMINER Type: DOCK

• 10/28/2004 - 19 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP